Autocrine stimulation from secreted CXCL12 has been shown to influence tumor behavior and phenotype [42], and CXCL12 expression in breast cancer cells has been correlated with decreased metastatic potential in humans [43]. This evidence concerns the gene CXCL12 and breast carcinoma.